NDC 80739-812

KRAZATI

Adagrasib

KRAZATI is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Mirati Therapeutics, Inc. The primary component is Adagrasib.

• Product ID: 80739-812_2c2c2067-66a3-4ff7-acf5-363b9c6f3e30
• NDC: 80739-812
• Product Type: Human Prescription Drug
• Proprietary Name: KRAZATI
• Generic Name: Adagrasib
• Dosage Form: Tablet, Coated
• Route of Administration: ORAL
• Marketing Start Date: 2022-12-12
• Marketing Category: NDA /
• Application Number: NDA216340
• Labeler Name: Mirati Therapeutics, Inc
• Substance Name: ADAGRASIB
• Active Ingredient Strength: 200 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2024-12-31

Packaging

NDC 80739-812-12

1 BOTTLE in 1 CARTON (80739-812-12) > 120 TABLET, COATED in 1 BOTTLE

• Marketing Start Date: 2022-12-12
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details